Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Müllerová (Cambridge, United Kingdom), D. Finch (Cambridge, United Kingdom), A. Agustí (Barcelona, Spain), M. Alacqua (Cambridge, United Kingdom), G. Anderson (Victoria, Australia), R. Beasley (Wellington, New Zealand), L. Belton (Cambridge, United Kingdom), A. De Giorgio-Miller (Cambridge, United Kingdom), J. Fitzgerald (Vancouver, Canada), R. Hughes (Cambridge, United Kingdom), I. Pavord (Oxford, United Kingdom), D. Price (Aberdeen, United Kingdom), E. Rapsomaniki (Cambridge, United Kingdom), M. Sadatsafavi (Vancouver, Canada), J. Vestbo (Manchester, United Kingdom), E. Bel (Amsterdam, Netherlands). Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study. 2990

Member's Comments

No comment yet.

Related content which might interest you: Factors associated with exacerbations in patients with COPD: NOVELTY study Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017 Year: 2017 Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016 COPD incidence in subjects with risk factors, chronic respiratory symptoms and normal spirometry: The PLATINO study> Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Factors associated with physician assessment of severity of asthma or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study Source: ERJ Open Res, 7 (4) 00471-2021; 10.1183/23120541.00471-2021 Year: 2021 LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort Source: Eur Respir J, 58 (3) 2003927; 10.1183/13993003.03927-2020 Year: 2021 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015